Deepali Gotur
Senior Scientist, Lead Discovery at Accent Therapeutics, Inc.- Claim this Profile
Click to upgrade to our gold package
for the full feature experience.
Topline Score
Bio
Experience
-
Accent Therapeutics, Inc.
-
United States
-
Biotechnology Research
-
1 - 100 Employee
-
Senior Scientist, Lead Discovery
-
Dec 2021 - Present
Lexington, Massachusetts, United States
-
-
Scientist, Lead Discovery
-
Aug 2020 - Dec 2021
Lexington, Massachusetts, United States
-
-
-
Tango Therapeutics
-
United States
-
Biotechnology Research
-
1 - 100 Employee
-
Scientist II
-
Apr 2018 - Jul 2020
Cambridge, MA
-
-
-
Forma Therapeutics
-
Biotechnology Research
-
1 - 100 Employee
-
Principal Research Associate - Lead Discovery and Optimization
-
Jan 2016 - Mar 2018
Watertown, MA Creative, organized, determined and have a strong zest to undertake challenges; able to plan and execute projects. Currently working on inheriting, validating and establishing a multi-disciplinary research projects in collaborative environment successfully.
-
-
Senior Research Associate - Biomolecular Screening
-
Jan 2012 - Dec 2015
Watertown, MA • Design and execute experiments support hit-to-lead track for multiple programs involving low to medium-throughput biochemical screening assay development and optimization • High-throughput screening with multiple biochemical assay formats using automation • Setting up protocols and troubleshooting liquid handlers, dispensers and plate readers (Wellmate; Tempest; Flexdrop; Microfill; Hamilton Bluestar; Synergy; Envision; BMG Pherastar) • Data analysis, reporting and coordination… Show more • Design and execute experiments support hit-to-lead track for multiple programs involving low to medium-throughput biochemical screening assay development and optimization • High-throughput screening with multiple biochemical assay formats using automation • Setting up protocols and troubleshooting liquid handlers, dispensers and plate readers (Wellmate; Tempest; Flexdrop; Microfill; Hamilton Bluestar; Synergy; Envision; BMG Pherastar) • Data analysis, reporting and coordination between chemistry, biology and hit-to-lead efforts
-
-
Research Associate-Hit to Lead
-
Jun 2010 - Dec 2011
-Assay development for HTL -Hit-to-lead optimization and follow up
-
-
-
Seaside Therapeutics
-
Biotechnology Research
-
1 - 100 Employee
-
Contractor/Research Associate
-
Nov 2009 - Aug 2010
=Aid in development of ELISA to detect biomarkers for autism and FragileX
-
-
-
-
Research Associate
-
Sep 2009 - Oct 2009
To study the effect of uremic toxins on Wnt signaling through cell culture model systems Molecular cloning, PCR, transformation using E.coli DH5, plasmid isolation, restriction digestion, ligation, reporter assays, Generation of stable cell lines using lentiviral vectors
-
-
-
Infinity Pharmaceuticals
-
United States
-
Pharmaceutical Manufacturing
-
200 - 300 Employee
-
Contract Research Investigator, Biochemistry
-
Nov 2008 - Aug 2009
Contract Research Investigator, Biochemistry Screening chemical analogs as enzyme inhibitors as cancer therapeutics using fluorescent enzyme inhibitor and enzyme kinetic assays. Protein expression studies in cancer cells using western blotting and ELISA. Inhibitor-mechanism of action studies using equilibrium dialysis & enzyme assays including Kon and Koff experiments
-
-
-
-
Summer Intern
-
Jun 2007 - Aug 2007
Tumor & Oncology Department Responsibilities included research in investigating a potential new anti-cancer agent. Lab techniques included ELISA, cellular based in vitro assays, and immunohistochemistry.
-
-
Education
-
University of Massachusetts Lowell
MS, Biotechnology -
University of Mumbai
MS, MicroBiology